Clinical Trial Update: Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating interferon alfa with or without interleukin-2 and fluorouracil in advanced/metastatic kidney cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Interferon Alfa (interferon alfa)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Medical Research Council | Conditions: Kidney Cancer | Phase 3 | Status: COMPLETED